Inventor
TIEFENTHALER GEORG
DE21 patents
⚠️ This page may combine multiple inventors who share the name “TIEFENTHALER GEORG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
19 patentsUS10364292B2Jul 30, 2019
Monovalent blood brain barrier shuttle modules
HOFFMANN LA ROCHE10 citations81
US8541204B2Sep 24, 2013
Polypeptide producing cells
HOFFMANN LA ROCHE12 citations81
US8354516B2Jan 15, 2013
Polypeptide producing cells
HOFFMANN LA ROCHE12 citations81
US10106612B2Oct 23, 2018
Method for selection and production of tailor-made highly selective and multi-specific targeting entities containing at least two different binding entities and uses thereof
HOFFMANN LA ROCHE2 citations72
US7208526B2Apr 24, 2007
Styrylsulfonamides
HOFFMANN LA ROCHE9 citations71
US10407511B2Sep 10, 2019
Covalently linked helicar-anti-helicar antibody conjugates and uses thereof
HOFFMANN LA ROCHE2 citations70
US7091345B2Aug 15, 2006
Amino-substituted dihydropyrimido[4,5-D]pyrimidinone derivatives
HOFFMANN LA ROCHE9 citations69
US9862779B2Jan 9, 2018
Method for the production and selection of molecules comprising at least two different entities and uses thereof
HOFFMANN LA ROCHE4 citations64
US11407836B2Aug 9, 2022
Method for selection and production of tailor-made highly selective and multi-specific targeting entities containing at least two different binding entities and uses thereof
HOFFMANN LA ROCHE0 citations62
US7625896B2Dec 1, 2009
Pyridylsulfonamide derivatives
HOFFMANN LA ROCHE3 citations61
US12103967B2Oct 1, 2024
Bispecific anti-CCL2 antibodies
HOFFMANN LA ROCHE0 citations56
US11981737B2May 14, 2024
Anti-HLA-G antibodies and use thereof
HOFFMANN LA ROCHE0 citations56
US11739142B2Aug 29, 2023
Bispecific anti-CCL2 antibodies
HOFFMANN LA ROCHE1 citations56
US12497434B2Dec 16, 2025
IL-37 fusion proteins and uses thereof
HOFFMANN LA ROCHE0 citations52
US11162127B2Nov 2, 2021
Enzymatic one-pot reaction for double polypeptide conjugation in a single step
HOFFMANN LA ROCHE0 citations52
US7208506B2Apr 24, 2007
Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents
HOFFMANN LA ROCHE0 citations49
US12157770B2Dec 3, 2024
Anti-HLA-G antibodies and methods of use thereof
HOFFMANN LA ROCHE0 citations48
US12466889B2Nov 11, 2025
Anti-HLA-G antibodies and use thereof
HOFFMANN LA ROCHE0 citations44
US12024548B2Jul 2, 2024
Rapid method for cloning and expression of cognate antibody variable gene segments
HOFFMANN LA ROCHE0 citations43